ilmofosine has been researched along with Experimental Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, MR; Schmähl, D | 1 |
| Fiebig, HH; Leder, GH; Löhr, GW; Wallbrecher, E; Winterhalter, BR | 1 |
2 other study(ies) available for ilmofosine and Experimental Leukemia
| Article | Year |
|---|---|
Modulation of chemical carcinogenesis in rats by alkyl lysophospholipids.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Leukemia, Experimental; Lysophospholipids; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasms, Experimental; Organophosphates; Organophosphorus Compounds; Phospholipid Ethers; Rats; Rats, Inbred Strains | 1987 |
In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cytotoxins; Glyceryl Ethers; Humans; Injections, Intraperitoneal; Leukemia, Experimental; Mice; Organophosphates; Organophosphorus Compounds; Phospholipid Ethers; Tumor Cells, Cultured | 1987 |